Lotemax Co 5 mg Eye drops, suspension

Lotemax Co 5 mg Eye drops, suspension

S4
PDF Leaflet Revision Date: 10 August 2022

API: Loteprednol Etabonate | Company: Soflens

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of bacterial ocular infections and inflammatory conditions.

Dosage (summary)

1-2 drops every 4-6 hours; may increase to 1-2 hours initially.

Special Populations

  • Elderly
  • Paediatric population

Pregnancy & Breastfeeding

Not established; contraindicated in pregnancy and breastfeeding.

Key Drug Interactions

  • CYP3A inhibitors
  • Neuromuscular blocking agents

Contraindications

  • Hypersensitivity to components
  • Viral infections of the eye

Common side effects

  • Burning/stinging
  • Increased intraocular pressure
  • Headache

Counselling Points

  • Do not touch the applicator tip
  • Avoid contact lenses during use
  • Monitor for increased intraocular pressure

Serious warnings

  • Prolonged use may cause glaucoma
  • Risk of secondary infections
Important Disclaimer

The Lotemax Co 5 mg Eye drops, suspension professional information leaflet below is the property of Soflens and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites